Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT02511821What this trial is testingElectronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryWho this might be right forStage I Adult Liver CancerStage I Colorectal CancerStage IA Gastric Cancer+28 more City of Hope Medical Center 22
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)UnknownNCT01618474What this trial is testingTrial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsWho this might be right forStomach Cancer Tianjin Medical University Cancer Institute and Hospital 100
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00978549What this trial is testingSymptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer+2 more Cambridge University Hospitals NHS Foundation Trust 320
Testing effectiveness (Phase 2)UnknownNCT02037048What this trial is testingFOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal AdenocarcinomaWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Gastric Cardia+3 more Case Comprehensive Cancer Center 63
Not applicableStudy completedNCT01939275What this trial is testing64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+10 more City of Hope Medical Center 8
Post-approval studies (Phase 4)Temporarily pausedNCT02366819What this trial is testingGenetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach CancerWho this might be right forEsophageal AdenocarcinomaGastric AdenocarcinomaStage IIB Gastric Cancer+6 more University of Chicago 36
Not applicableStudy completedNCT01846520What this trial is testingFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersWho this might be right forHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more City of Hope Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT01178944What this trial is testingPralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Undifferentiated CarcinomaGastric Adenocarcinoma+14 more Roswell Park Cancer Institute 35
Testing effectiveness (Phase 2)Study completedNCT00061932What this trial is testingBortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or StomachWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more National Cancer Institute (NCI) 41
Early research (Phase 1)Ended earlyNCT01233505What this trial is testingVeliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsWho this might be right forAdenocarcinoma of the PancreasAdenocarcinoma of the StomachBRCA1 Mutation Carrier+23 more National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)UnknownNCT04351867What this trial is testingA Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric CancerWho this might be right forStomach Neoplasms LiNing 196
Testing effectiveness (Phase 2)Study completedNCT01360086What this trial is testingFluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionGastric Cancer Federation Francophone de Cancerologie Digestive 65
Very early researchActive Not RecruitingNCT05041153What this trial is testingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal AdenocarcinomaWho this might be right forAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Gastric Cancer AJCC v8+30 more M.D. Anderson Cancer Center 15
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Testing effectiveness (Phase 2)Study completedNCT00084604What this trial is testingIrinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more National Cancer Institute (NCI) 47